ARTERIAL DISEASE MULTIPLE INTERVENTION TRIAL

动脉疾病多重干预试验

• 批准号: 3767235
• 负责人: JOHN ROBIN CROUSE
• 金额: --
• 依托单位: WAKE FOREST UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3767235
• 关键词: cardiovascular disorder prevention; disease /disorder proneness /risk; human subject; peripheral blood vessel disorder

It is known that individuals with peripheral arterial disease are at increased risk for cardiovascular morbidity and mortality. In order to facilitate design of a trial to evaluate the effects of intervention on risk factors on morbidity and mortality in such patients a feasibility study (ADMIT) has been designed to evaluate the ability to recruit, treat and retain volunteers in anticipation of a large scale multi-center study focusing on risk factor reduction.

众所周知，患有外周动脉疾病的个体在 增加心血管疾病发病率和死亡率的风险。 为了 促进试验设计，以评估干预对 危险因素对此类患者发病率和死亡率的影响 研究（ADMIT）的目的是评估招募、治疗 并保留志愿者以进行大规模多中心研究 重点是降低风险因素。